Biome Signs Australian Manufacturing Agreement

• Biome Australia signs agreement with Specialty Probiotics Australia for onshore production.
• Agreement requires no upfront capital investment from Biome.
• Expected gross margin increase to 65%+ over 18 months.

Biome Australia has signed a commercial manufacturing agreement with Specialty Probiotics Australia to transition its Activated Probiotics range production to Australia. The agreement is binding and does not require Biome to make any upfront capital investment. Biome's gross margin is expected to increase progressively to 65%+ over the next 18 months as a result of onshore production. The first commercial batch is targeted for September 2026, with the full range to progressively transition over approximately 18 months. Australian-made production will add a point of difference across global markets and further Biome's positive impact as a certified B Corporation. Biome will retain its European supply partnerships to service EU markets, providing supply chain diversification and de-risking.

Biome's gross margin expected to increase to 65%+ over 18 months.

The transition to onshore manufacturing is expected to deliver meaningful improvements to Biome's working capital position and gross margin.